Calpain 13 Activators

Calpain 13 Activators, as a class, would encompass compounds that can indirectly lead to the activation of Calpain 13, primarily by modulating intracellular calcium levels. These activators can function through various mechanisms: some disrupt the calcium sequestration into the endoplasmic reticulum (ER) by inhibiting the SERCA pump, as seen with Thapsigargin and Cyclopiazonic acid, leading to an increase in cytosolic calcium that can enhance the proteolytic activity of Calpain 13. Others, like A23187 and Ryanodine, act directly on calcium channels or receptors to facilitate the release of calcium from intracellular stores, increasing the local concentration of calcium necessary for theCalpain 13 activation, and therefore enhancing Calpain 13's functional activity. Compounds such as 4-Chloro-m-cresol and Caffeine induce calcium release through ryanodine receptor channels, which play a pivotal role in the regulation of intracellular calcium. These compounds ensure that the intracellular milieu is rich in calcium ions, which is a requisite for Calpain 13 activation. Carbachol, by acting as a cholinergic agonist, increases intracellular calcium by mobilizing calcium from the ER, thereby providing an environment conducive to Calpain 13 activation. The functional activity of Calpain 13 is further influenced by compounds that modulate the cellular calcium channels. For instance, calcium channel blockers like Verapamil and Nicardipine can indirectly lead to an increase in intracellular calcium through homeostatic mechanisms that attempt to maintain calcium balance, possibly resulting in the upregulation of Calpain 13 activity.